nodes	percent_of_prediction	percent_of_DWPC	metapath
Topiramate—GRIK3—seminal vesicle—sarcoma	0.00801	0.0766	CbGeAlD
Topiramate—CA2—periosteum—sarcoma	0.00683	0.0653	CbGeAlD
Topiramate—GRIK4—testis—sarcoma	0.00572	0.0547	CbGeAlD
Topiramate—GRIK3—tendon—sarcoma	0.00504	0.0482	CbGeAlD
Topiramate—GRIK3—testis—sarcoma	0.00417	0.0399	CbGeAlD
Topiramate—GRIK5—testis—sarcoma	0.00417	0.0399	CbGeAlD
Topiramate—GRIA3—testis—sarcoma	0.00368	0.0352	CbGeAlD
Topiramate—CA5B—mammary gland—sarcoma	0.00354	0.0339	CbGeAlD
Topiramate—GRIA3—liver—sarcoma	0.00348	0.0333	CbGeAlD
Topiramate—GRIA2—embryo—sarcoma	0.00319	0.0306	CbGeAlD
Topiramate—GRIK5—lymph node—sarcoma	0.00302	0.0289	CbGeAlD
Topiramate—GRIK3—lymph node—sarcoma	0.00302	0.0289	CbGeAlD
Topiramate—CA5A—liver—sarcoma	0.00289	0.0276	CbGeAlD
Topiramate—CA12—connective tissue—sarcoma	0.00232	0.0222	CbGeAlD
Topiramate—CA5B—hematopoietic system—sarcoma	0.00216	0.0207	CbGeAlD
Topiramate—CA9—tendon—sarcoma	0.00215	0.0206	CbGeAlD
Topiramate—GRIA1—testis—sarcoma	0.00197	0.0188	CbGeAlD
Topiramate—CA1—hematopoietic system—sarcoma	0.00191	0.0182	CbGeAlD
Topiramate—CA9—testis—sarcoma	0.00178	0.0171	CbGeAlD
Topiramate—CA5B—cardiac atrium—sarcoma	0.00164	0.0157	CbGeAlD
Topiramate—SCN5A—cardiac atrium—sarcoma	0.00159	0.0152	CbGeAlD
Topiramate—CA4—seminal vesicle—sarcoma	0.00157	0.015	CbGeAlD
Topiramate—GRIA2—testis—sarcoma	0.00156	0.0149	CbGeAlD
Topiramate—GRIA1—Mecp2 and Associated Rett Syndrome—CREB1—sarcoma	0.00147	0.00717	CbGpPWpGaD
Topiramate—GRIA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CREB1—sarcoma	0.00144	0.007	CbGpPWpGaD
Topiramate—CA5B—tendon—sarcoma	0.00143	0.0137	CbGeAlD
Topiramate—GRIA2—Hypothetical Network for Drug Addiction—CREB1—sarcoma	0.00142	0.00694	CbGpPWpGaD
Topiramate—GRIK1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—sarcoma	0.0014	0.00681	CbGpPWpGaD
Topiramate—GRIK3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—sarcoma	0.0014	0.00681	CbGpPWpGaD
Topiramate—CA2—embryo—sarcoma	0.00138	0.0132	CbGeAlD
Topiramate—GRIK4—Transmission across Chemical Synapses—CREB1—sarcoma	0.00137	0.00666	CbGpPWpGaD
Topiramate—GRIK5—Transmission across Chemical Synapses—CREB1—sarcoma	0.00137	0.00666	CbGpPWpGaD
Topiramate—CYP2C19—hematopoietic system—sarcoma	0.00135	0.0129	CbGeAlD
Topiramate—CA1—lymphoid tissue—sarcoma	0.00134	0.0128	CbGeAlD
Topiramate—CA2—seminal vesicle—sarcoma	0.0013	0.0124	CbGeAlD
Topiramate—GRIK3—Transmission across Chemical Synapses—CREB1—sarcoma	0.00127	0.00619	CbGpPWpGaD
Topiramate—GRIK1—Transmission across Chemical Synapses—CREB1—sarcoma	0.00127	0.00619	CbGpPWpGaD
Topiramate—GRIA3—Activation of NMDA receptor upon glutamate binding and postsynaptic events—HRAS—sarcoma	0.00126	0.00617	CbGpPWpGaD
Topiramate—GRIA2—Glutamate Binding, Activation of AMPA Receptors and Synaptic Plasticity—MDM2—sarcoma	0.00124	0.00605	CbGpPWpGaD
Topiramate—CA2—hematopoietic system—sarcoma	0.00124	0.0118	CbGeAlD
Topiramate—CA1—bone marrow—sarcoma	0.00122	0.0117	CbGeAlD
Topiramate—CA9—Cellular response to hypoxia—VEGFA—sarcoma	0.0012	0.00585	CbGpPWpGaD
Topiramate—CA2—connective tissue—sarcoma	0.00119	0.0114	CbGeAlD
Topiramate—GRIA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—sarcoma	0.00119	0.00579	CbGpPWpGaD
Topiramate—GRIA1—BDNF signaling pathway—PLCG1—sarcoma	0.00119	0.00579	CbGpPWpGaD
Topiramate—CA5B—testis—sarcoma	0.00118	0.0113	CbGeAlD
Topiramate—SCN5A—Cardiac Progenitor Differentiation—PDGFRA—sarcoma	0.00117	0.00572	CbGpPWpGaD
Topiramate—GRIA2—Activation of NMDA receptor upon glutamate binding and postsynaptic events—CREB1—sarcoma	0.00117	0.00569	CbGpPWpGaD
Topiramate—CA4—cardiac atrium—sarcoma	0.00113	0.0108	CbGeAlD
Topiramate—GRIK4—Transmission across Chemical Synapses—MDM2—sarcoma	0.00113	0.00551	CbGpPWpGaD
Topiramate—GRIK5—Transmission across Chemical Synapses—MDM2—sarcoma	0.00113	0.00551	CbGpPWpGaD
Topiramate—GABRB2—testis—sarcoma	0.00111	0.0106	CbGeAlD
Topiramate—CA2—smooth muscle tissue—sarcoma	0.00109	0.0104	CbGeAlD
Topiramate—GRIA4—Transmission across Chemical Synapses—CREB1—sarcoma	0.00108	0.00526	CbGpPWpGaD
Topiramate—CA2—skin of body—sarcoma	0.00107	0.0103	CbGeAlD
Topiramate—GRIK1—Transmission across Chemical Synapses—MDM2—sarcoma	0.00105	0.00512	CbGpPWpGaD
Topiramate—GRIK3—Transmission across Chemical Synapses—MDM2—sarcoma	0.00105	0.00512	CbGpPWpGaD
Topiramate—GRIK5—Neuronal System—CREB1—sarcoma	0.00105	0.0051	CbGpPWpGaD
Topiramate—GRIK4—Neuronal System—CREB1—sarcoma	0.00105	0.0051	CbGpPWpGaD
Topiramate—GRIA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CREB1—sarcoma	0.00104	0.00509	CbGpPWpGaD
Topiramate—GRIA3—BDNF signaling pathway—CREB1—sarcoma	0.00102	0.00497	CbGpPWpGaD
Topiramate—SCN5A—Cardiac Progenitor Differentiation—KDR—sarcoma	0.000988	0.00482	CbGpPWpGaD
Topiramate—CA1—liver—sarcoma	0.000988	0.00945	CbGeAlD
Topiramate—CA4—tendon—sarcoma	0.000986	0.00944	CbGeAlD
Topiramate—SCN1A—Axon guidance—EZR—sarcoma	0.000975	0.00476	CbGpPWpGaD
Topiramate—GRIK3—Neuronal System—CREB1—sarcoma	0.000972	0.00474	CbGpPWpGaD
Topiramate—GRIK1—Neuronal System—CREB1—sarcoma	0.000972	0.00474	CbGpPWpGaD
Topiramate—CA4—bone marrow—sarcoma	0.000955	0.00914	CbGeAlD
Topiramate—CA2—cardiac atrium—sarcoma	0.000938	0.00898	CbGeAlD
Topiramate—GRIA2—N-cadherin signaling events—CTNNB1—sarcoma	0.000924	0.00451	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—MYOG—sarcoma	0.000918	0.00448	CbGpPWpGaD
Topiramate—SCN5A—Cardiac Progenitor Differentiation—KIT—sarcoma	0.00091	0.00444	CbGpPWpGaD
Topiramate—GRIA4—Transmission across Chemical Synapses—MDM2—sarcoma	0.000893	0.00435	CbGpPWpGaD
Topiramate—CA9—HIF-1-alpha transcription factor network—CREB1—sarcoma	0.000879	0.00429	CbGpPWpGaD
Topiramate—CA2—lymphoid tissue—sarcoma	0.00087	0.00832	CbGeAlD
Topiramate—CA1—C-MYB transcription factor network—KIT—sarcoma	0.000866	0.00422	CbGpPWpGaD
Topiramate—GRIK4—Neuronal System—MDM2—sarcoma	0.000865	0.00422	CbGpPWpGaD
Topiramate—GRIK5—Neuronal System—MDM2—sarcoma	0.000865	0.00422	CbGpPWpGaD
Topiramate—GRIA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—sarcoma	0.000863	0.00421	CbGpPWpGaD
Topiramate—CA5B—lymph node—sarcoma	0.000858	0.00821	CbGeAlD
Topiramate—GRIA1—Amyotrophic lateral sclerosis (ALS)—TP53—sarcoma	0.000842	0.00411	CbGpPWpGaD
Topiramate—GRIA2—BDNF signaling pathway—PLCG1—sarcoma	0.00083	0.00405	CbGpPWpGaD
Topiramate—GRIA4—Neuronal System—CREB1—sarcoma	0.000827	0.00403	CbGpPWpGaD
Topiramate—GRIK4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—sarcoma	0.000824	0.00402	CbGpPWpGaD
Topiramate—GRIK5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—sarcoma	0.000824	0.00402	CbGpPWpGaD
Topiramate—CA2—tendon—sarcoma	0.000818	0.00783	CbGeAlD
Topiramate—CA4—testis—sarcoma	0.000817	0.00781	CbGeAlD
Topiramate—GRIK3—Neuronal System—MDM2—sarcoma	0.000805	0.00392	CbGpPWpGaD
Topiramate—GRIK1—Neuronal System—MDM2—sarcoma	0.000805	0.00392	CbGpPWpGaD
Topiramate—CYP3A4—hematopoietic system—sarcoma	0.000797	0.00763	CbGeAlD
Topiramate—CA2—bone marrow—sarcoma	0.000792	0.00758	CbGeAlD
Topiramate—GRIA3—Transmission across Chemical Synapses—CREB1—sarcoma	0.000784	0.00382	CbGpPWpGaD
Topiramate—GRIK3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—sarcoma	0.000766	0.00374	CbGpPWpGaD
Topiramate—GRIK1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—sarcoma	0.000766	0.00374	CbGpPWpGaD
Topiramate—GRIA1—Activation of NMDA receptor upon glutamate binding and postsynaptic events—HRAS—sarcoma	0.000758	0.00369	CbGpPWpGaD
Topiramate—CA1—lymph node—sarcoma	0.000757	0.00725	CbGeAlD
Topiramate—GRIA3—BDNF signaling pathway—JUN—sarcoma	0.000733	0.00358	CbGpPWpGaD
Topiramate—GRIA3—BDNF signaling pathway—CTNNB1—sarcoma	0.000728	0.00355	CbGpPWpGaD
Topiramate—CYP2C19—liver—sarcoma	0.000699	0.00668	CbGeAlD
Topiramate—SCN1A—Developmental Biology—EZR—sarcoma	0.000696	0.00339	CbGpPWpGaD
Topiramate—SCN5A—Axon guidance—EZR—sarcoma	0.000686	0.00334	CbGpPWpGaD
Topiramate—GRIA4—Neuronal System—MDM2—sarcoma	0.000684	0.00334	CbGpPWpGaD
Topiramate—CA2—testis—sarcoma	0.000677	0.00648	CbGeAlD
Topiramate—GRIA3—BDNF signaling pathway—SRC—sarcoma	0.000658	0.00321	CbGpPWpGaD
Topiramate—CYP2C19—Melatonin metabolism and effects—FOXO1—sarcoma	0.000655	0.00319	CbGpPWpGaD
Topiramate—GRIA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—sarcoma	0.000652	0.00318	CbGpPWpGaD
Topiramate—GRIA3—Transmission across Chemical Synapses—MDM2—sarcoma	0.000649	0.00316	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—MYOG—sarcoma	0.000646	0.00315	CbGpPWpGaD
Topiramate—CA2—liver—sarcoma	0.00064	0.00613	CbGeAlD
Topiramate—CA9—HIF-1-alpha transcription factor network—JUN—sarcoma	0.000632	0.00308	CbGpPWpGaD
Topiramate—GRIA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CREB1—sarcoma	0.000625	0.00305	CbGpPWpGaD
Topiramate—GRIK5—Transmission across Chemical Synapses—HRAS—sarcoma	0.00062	0.00302	CbGpPWpGaD
Topiramate—GRIK4—Transmission across Chemical Synapses—HRAS—sarcoma	0.00062	0.00302	CbGpPWpGaD
Topiramate—GRIA1—BDNF signaling pathway—CREB1—sarcoma	0.000611	0.00298	CbGpPWpGaD
Topiramate—CYP2C19—Constitutive Androstane Receptor Pathway—FOXO1—sarcoma	0.000605	0.00295	CbGpPWpGaD
Topiramate—GRIA3—Neuronal System—CREB1—sarcoma	0.000601	0.00293	CbGpPWpGaD
Topiramate—CA1—C-MYB transcription factor network—CCND1—sarcoma	0.000594	0.0029	CbGpPWpGaD
Topiramate—CA4—lymph node—sarcoma	0.000592	0.00566	CbGeAlD
Topiramate—GRIK1—Transmission across Chemical Synapses—HRAS—sarcoma	0.000576	0.00281	CbGpPWpGaD
Topiramate—GRIK3—Transmission across Chemical Synapses—HRAS—sarcoma	0.000576	0.00281	CbGpPWpGaD
Topiramate—SCN1A—Axon guidance—PTPRC—sarcoma	0.000575	0.0028	CbGpPWpGaD
Topiramate—GRIK2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CREB1—sarcoma	0.000571	0.00279	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—MYOD1—sarcoma	0.000567	0.00277	CbGpPWpGaD
Topiramate—SCN1A—Axon guidance—PLCG1—sarcoma	0.000563	0.00274	CbGpPWpGaD
Topiramate—CA9—HIF-1-alpha transcription factor network—VEGFA—sarcoma	0.000552	0.00269	CbGpPWpGaD
Topiramate—GRIA2—Activation of NMDA receptor upon glutamate binding and postsynaptic events—HRAS—sarcoma	0.00053	0.00258	CbGpPWpGaD
Topiramate—GRIA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—sarcoma	0.000517	0.00252	CbGpPWpGaD
Topiramate—CA1—C-MYB transcription factor network—NRAS—sarcoma	0.000512	0.00249	CbGpPWpGaD
Topiramate—GRIA3—Neuronal System—MDM2—sarcoma	0.000497	0.00242	CbGpPWpGaD
Topiramate—SCN1A—L1CAM interactions—SRC—sarcoma	0.000494	0.00241	CbGpPWpGaD
Topiramate—CA2—lymph node—sarcoma	0.000491	0.0047	CbGeAlD
Topiramate—GRIA4—Transmission across Chemical Synapses—HRAS—sarcoma	0.00049	0.00239	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—EZR—sarcoma	0.000489	0.00239	CbGpPWpGaD
Topiramate—CA1—C-MYB transcription factor network—MYC—sarcoma	0.000477	0.00232	CbGpPWpGaD
Topiramate—GRIK4—Neuronal System—HRAS—sarcoma	0.000475	0.00232	CbGpPWpGaD
Topiramate—GRIK5—Neuronal System—HRAS—sarcoma	0.000475	0.00232	CbGpPWpGaD
Topiramate—GRIA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—sarcoma	0.000474	0.00231	CbGpPWpGaD
Topiramate—GRIK2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—sarcoma	0.000473	0.00231	CbGpPWpGaD
Topiramate—GRIA1—Transmission across Chemical Synapses—CREB1—sarcoma	0.00047	0.00229	CbGpPWpGaD
Topiramate—GRIA3—BDNF signaling pathway—HRAS—sarcoma	0.000463	0.00226	CbGpPWpGaD
Topiramate—GRIK3—Neuronal System—HRAS—sarcoma	0.000441	0.00215	CbGpPWpGaD
Topiramate—GRIK1—Neuronal System—HRAS—sarcoma	0.000441	0.00215	CbGpPWpGaD
Topiramate—CA1—C-MYB transcription factor network—KRAS—sarcoma	0.00044	0.00215	CbGpPWpGaD
Topiramate—GRIA1—BDNF signaling pathway—JUN—sarcoma	0.000439	0.00214	CbGpPWpGaD
Topiramate—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CREB1—sarcoma	0.000437	0.00213	CbGpPWpGaD
Topiramate—GRIA1—BDNF signaling pathway—CTNNB1—sarcoma	0.000436	0.00213	CbGpPWpGaD
Topiramate—SCN1A—L1CAM interactions—EGFR—sarcoma	0.000433	0.00211	CbGpPWpGaD
Topiramate—GRIK2—Transmission across Chemical Synapses—CREB1—sarcoma	0.00043	0.00209	CbGpPWpGaD
Topiramate—GRIA2—BDNF signaling pathway—CREB1—sarcoma	0.000427	0.00208	CbGpPWpGaD
Topiramate—CYP3A4—liver—sarcoma	0.000413	0.00395	CbGeAlD
Topiramate—SCN1A—Developmental Biology—PTPRC—sarcoma	0.00041	0.002	CbGpPWpGaD
Topiramate—Vomiting—Dactinomycin—sarcoma	0.000406	0.000589	CcSEcCtD
Topiramate—Rash—Thiotepa—sarcoma	0.000406	0.000588	CcSEcCtD
Topiramate—Bronchitis—Doxorubicin—sarcoma	0.000406	0.000588	CcSEcCtD
Topiramate—Dermatitis—Thiotepa—sarcoma	0.000406	0.000588	CcSEcCtD
Topiramate—SCN5A—Axon guidance—PTPRC—sarcoma	0.000404	0.00197	CbGpPWpGaD
Topiramate—Headache—Thiotepa—sarcoma	0.000404	0.000584	CcSEcCtD
Topiramate—Stevens-Johnson syndrome—Epirubicin—sarcoma	0.000403	0.000584	CcSEcCtD
Topiramate—Rash—Dactinomycin—sarcoma	0.000403	0.000584	CcSEcCtD
Topiramate—Decreased appetite—Etoposide—sarcoma	0.000402	0.000583	CcSEcCtD
Topiramate—SCN1A—Developmental Biology—PLCG1—sarcoma	0.000401	0.00196	CbGpPWpGaD
Topiramate—Pancytopenia—Doxorubicin—sarcoma	0.000401	0.00058	CcSEcCtD
Topiramate—Renal failure—Epirubicin—sarcoma	0.0004	0.000579	CcSEcCtD
Topiramate—Gastrointestinal disorder—Etoposide—sarcoma	0.000399	0.000579	CcSEcCtD
Topiramate—Asthenia—Mitoxantrone—sarcoma	0.000399	0.000578	CcSEcCtD
Topiramate—Fatigue—Etoposide—sarcoma	0.000399	0.000578	CcSEcCtD
Topiramate—SCN5A—Developmental Biology—MYOD1—sarcoma	0.000399	0.00194	CbGpPWpGaD
Topiramate—Neuropathy peripheral—Epirubicin—sarcoma	0.000399	0.000577	CcSEcCtD
Topiramate—Stomatitis—Epirubicin—sarcoma	0.000396	0.000574	CcSEcCtD
Topiramate—Pain—Etoposide—sarcoma	0.000396	0.000573	CcSEcCtD
Topiramate—Constipation—Etoposide—sarcoma	0.000396	0.000573	CcSEcCtD
Topiramate—SCN5A—Axon guidance—PLCG1—sarcoma	0.000395	0.00193	CbGpPWpGaD
Topiramate—Conjunctivitis—Epirubicin—sarcoma	0.000395	0.000573	CcSEcCtD
Topiramate—Urinary tract infection—Epirubicin—sarcoma	0.000395	0.000573	CcSEcCtD
Topiramate—Dysuria—Doxorubicin—sarcoma	0.000395	0.000572	CcSEcCtD
Topiramate—Neutropenia—Doxorubicin—sarcoma	0.000395	0.000572	CcSEcCtD
Topiramate—GRIA1—BDNF signaling pathway—SRC—sarcoma	0.000394	0.00192	CbGpPWpGaD
Topiramate—Upper respiratory tract infection—Doxorubicin—sarcoma	0.000392	0.000568	CcSEcCtD
Topiramate—Diarrhoea—Vincristine—sarcoma	0.000391	0.000566	CcSEcCtD
Topiramate—Pollakiuria—Doxorubicin—sarcoma	0.00039	0.000565	CcSEcCtD
Topiramate—GRIA1—Transmission across Chemical Synapses—MDM2—sarcoma	0.000389	0.00189	CbGpPWpGaD
Topiramate—Haematuria—Epirubicin—sarcoma	0.000388	0.000562	CcSEcCtD
Topiramate—Photosensitivity reaction—Doxorubicin—sarcoma	0.000385	0.000558	CcSEcCtD
Topiramate—Weight increased—Doxorubicin—sarcoma	0.000384	0.000556	CcSEcCtD
Topiramate—Epistaxis—Epirubicin—sarcoma	0.000384	0.000556	CcSEcCtD
Topiramate—Nausea—Thiotepa—sarcoma	0.000383	0.000554	CcSEcCtD
Topiramate—Weight decreased—Doxorubicin—sarcoma	0.000382	0.000553	CcSEcCtD
Topiramate—Sinusitis—Epirubicin—sarcoma	0.000382	0.000553	CcSEcCtD
Topiramate—Feeling abnormal—Etoposide—sarcoma	0.000381	0.000552	CcSEcCtD
Topiramate—Hyperglycaemia—Doxorubicin—sarcoma	0.000381	0.000551	CcSEcCtD
Topiramate—Diarrhoea—Mitoxantrone—sarcoma	0.000381	0.000551	CcSEcCtD
Topiramate—Nausea—Dactinomycin—sarcoma	0.00038	0.00055	CcSEcCtD
Topiramate—Agranulocytosis—Epirubicin—sarcoma	0.000379	0.00055	CcSEcCtD
Topiramate—Pneumonia—Doxorubicin—sarcoma	0.000378	0.000548	CcSEcCtD
Topiramate—Gastrointestinal pain—Etoposide—sarcoma	0.000378	0.000548	CcSEcCtD
Topiramate—Dizziness—Vincristine—sarcoma	0.000378	0.000547	CcSEcCtD
Topiramate—Infestation NOS—Doxorubicin—sarcoma	0.000376	0.000545	CcSEcCtD
Topiramate—Infestation—Doxorubicin—sarcoma	0.000376	0.000545	CcSEcCtD
Topiramate—GRIA4—Neuronal System—HRAS—sarcoma	0.000375	0.00183	CbGpPWpGaD
Topiramate—CA1—C-MYB transcription factor network—HRAS—sarcoma	0.000374	0.00183	CbGpPWpGaD
Topiramate—Stevens-Johnson syndrome—Doxorubicin—sarcoma	0.000373	0.00054	CcSEcCtD
Topiramate—Bradycardia—Epirubicin—sarcoma	0.000372	0.000538	CcSEcCtD
Topiramate—Renal failure—Doxorubicin—sarcoma	0.00037	0.000536	CcSEcCtD
Topiramate—Neuropathy peripheral—Doxorubicin—sarcoma	0.000369	0.000534	CcSEcCtD
Topiramate—Urticaria—Etoposide—sarcoma	0.000368	0.000532	CcSEcCtD
Topiramate—Haemoglobin—Epirubicin—sarcoma	0.000367	0.000531	CcSEcCtD
Topiramate—Stomatitis—Doxorubicin—sarcoma	0.000367	0.000531	CcSEcCtD
Topiramate—Rhinitis—Epirubicin—sarcoma	0.000366	0.00053	CcSEcCtD
Topiramate—Body temperature increased—Etoposide—sarcoma	0.000366	0.00053	CcSEcCtD
Topiramate—Abdominal pain—Etoposide—sarcoma	0.000366	0.00053	CcSEcCtD
Topiramate—Conjunctivitis—Doxorubicin—sarcoma	0.000366	0.00053	CcSEcCtD
Topiramate—Urinary tract infection—Doxorubicin—sarcoma	0.000366	0.00053	CcSEcCtD
Topiramate—SCN5A—SIDS Susceptibility Pathways—CREB1—sarcoma	0.000365	0.00178	CbGpPWpGaD
Topiramate—Haemorrhage—Epirubicin—sarcoma	0.000365	0.000529	CcSEcCtD
Topiramate—Hepatitis—Epirubicin—sarcoma	0.000365	0.000529	CcSEcCtD
Topiramate—CYP3A4—Constitutive Androstane Receptor Pathway—FOXO1—sarcoma	0.000364	0.00178	CbGpPWpGaD
Topiramate—Hypoaesthesia—Epirubicin—sarcoma	0.000363	0.000526	CcSEcCtD
Topiramate—Vomiting—Vincristine—sarcoma	0.000363	0.000526	CcSEcCtD
Topiramate—Pharyngitis—Epirubicin—sarcoma	0.000362	0.000525	CcSEcCtD
Topiramate—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—sarcoma	0.000362	0.00176	CbGpPWpGaD
Topiramate—Urinary tract disorder—Epirubicin—sarcoma	0.000361	0.000522	CcSEcCtD
Topiramate—Rash—Vincristine—sarcoma	0.00036	0.000522	CcSEcCtD
Topiramate—GRIA1—Neuronal System—CREB1—sarcoma	0.00036	0.00175	CbGpPWpGaD
Topiramate—Dermatitis—Vincristine—sarcoma	0.00036	0.000521	CcSEcCtD
Topiramate—Oedema peripheral—Epirubicin—sarcoma	0.00036	0.000521	CcSEcCtD
Topiramate—Haematuria—Doxorubicin—sarcoma	0.000359	0.00052	CcSEcCtD
Topiramate—Connective tissue disorder—Epirubicin—sarcoma	0.000359	0.00052	CcSEcCtD
Topiramate—Urethral disorder—Epirubicin—sarcoma	0.000358	0.000518	CcSEcCtD
Topiramate—Headache—Vincristine—sarcoma	0.000358	0.000518	CcSEcCtD
Topiramate—GRIA3—Transmission across Chemical Synapses—HRAS—sarcoma	0.000356	0.00174	CbGpPWpGaD
Topiramate—GRIK2—Transmission across Chemical Synapses—MDM2—sarcoma	0.000355	0.00173	CbGpPWpGaD
Topiramate—Epistaxis—Doxorubicin—sarcoma	0.000355	0.000514	CcSEcCtD
Topiramate—Vomiting—Mitoxantrone—sarcoma	0.000354	0.000512	CcSEcCtD
Topiramate—Sinusitis—Doxorubicin—sarcoma	0.000353	0.000511	CcSEcCtD
Topiramate—Visual impairment—Epirubicin—sarcoma	0.000352	0.00051	CcSEcCtD
Topiramate—Agranulocytosis—Doxorubicin—sarcoma	0.000351	0.000509	CcSEcCtD
Topiramate—Rash—Mitoxantrone—sarcoma	0.000351	0.000508	CcSEcCtD
Topiramate—Dermatitis—Mitoxantrone—sarcoma	0.00035	0.000508	CcSEcCtD
Topiramate—Headache—Mitoxantrone—sarcoma	0.000348	0.000505	CcSEcCtD
Topiramate—SCN5A—L1CAM interactions—SRC—sarcoma	0.000347	0.00169	CbGpPWpGaD
Topiramate—Erythema multiforme—Epirubicin—sarcoma	0.000345	0.0005	CcSEcCtD
Topiramate—Bradycardia—Doxorubicin—sarcoma	0.000344	0.000498	CcSEcCtD
Topiramate—Eye disorder—Epirubicin—sarcoma	0.000341	0.000494	CcSEcCtD
Topiramate—Hypersensitivity—Etoposide—sarcoma	0.000341	0.000494	CcSEcCtD
Topiramate—Tinnitus—Epirubicin—sarcoma	0.00034	0.000493	CcSEcCtD
Topiramate—Haemoglobin—Doxorubicin—sarcoma	0.000339	0.000492	CcSEcCtD
Topiramate—Nausea—Vincristine—sarcoma	0.000339	0.000491	CcSEcCtD
Topiramate—Cardiac disorder—Epirubicin—sarcoma	0.000339	0.000491	CcSEcCtD
Topiramate—Flushing—Epirubicin—sarcoma	0.000339	0.000491	CcSEcCtD
Topiramate—Rhinitis—Doxorubicin—sarcoma	0.000339	0.00049	CcSEcCtD
Topiramate—Haemorrhage—Doxorubicin—sarcoma	0.000338	0.000489	CcSEcCtD
Topiramate—Hepatitis—Doxorubicin—sarcoma	0.000338	0.000489	CcSEcCtD
Topiramate—Hypoaesthesia—Doxorubicin—sarcoma	0.000336	0.000487	CcSEcCtD
Topiramate—Pharyngitis—Doxorubicin—sarcoma	0.000335	0.000486	CcSEcCtD
Topiramate—Urinary tract disorder—Doxorubicin—sarcoma	0.000334	0.000483	CcSEcCtD
Topiramate—Oedema peripheral—Doxorubicin—sarcoma	0.000333	0.000482	CcSEcCtD
Topiramate—Asthenia—Etoposide—sarcoma	0.000332	0.000481	CcSEcCtD
Topiramate—Connective tissue disorder—Doxorubicin—sarcoma	0.000332	0.000481	CcSEcCtD
Topiramate—Angiopathy—Epirubicin—sarcoma	0.000331	0.00048	CcSEcCtD
Topiramate—Urethral disorder—Doxorubicin—sarcoma	0.000331	0.00048	CcSEcCtD
Topiramate—Nausea—Mitoxantrone—sarcoma	0.00033	0.000479	CcSEcCtD
Topiramate—SCN1A—Axon guidance—KDR—sarcoma	0.00033	0.00161	CbGpPWpGaD
Topiramate—Immune system disorder—Epirubicin—sarcoma	0.00033	0.000478	CcSEcCtD
Topiramate—GRIK2—Neuronal System—CREB1—sarcoma	0.000329	0.0016	CbGpPWpGaD
Topiramate—Mediastinal disorder—Epirubicin—sarcoma	0.000329	0.000477	CcSEcCtD
Topiramate—GRIA2—Transmission across Chemical Synapses—CREB1—sarcoma	0.000329	0.0016	CbGpPWpGaD
Topiramate—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CREB1—sarcoma	0.000328	0.0016	CbGpPWpGaD
Topiramate—Chills—Epirubicin—sarcoma	0.000328	0.000474	CcSEcCtD
Topiramate—Pruritus—Etoposide—sarcoma	0.000327	0.000474	CcSEcCtD
Topiramate—Visual impairment—Doxorubicin—sarcoma	0.000326	0.000471	CcSEcCtD
Topiramate—Alopecia—Epirubicin—sarcoma	0.000323	0.000467	CcSEcCtD
Topiramate—Mental disorder—Epirubicin—sarcoma	0.00032	0.000463	CcSEcCtD
Topiramate—Erythema multiforme—Doxorubicin—sarcoma	0.000319	0.000463	CcSEcCtD
Topiramate—Erythema—Epirubicin—sarcoma	0.000318	0.00046	CcSEcCtD
Topiramate—Malnutrition—Epirubicin—sarcoma	0.000318	0.00046	CcSEcCtD
Topiramate—Diarrhoea—Etoposide—sarcoma	0.000317	0.000459	CcSEcCtD
Topiramate—Eye disorder—Doxorubicin—sarcoma	0.000316	0.000457	CcSEcCtD
Topiramate—Tinnitus—Doxorubicin—sarcoma	0.000315	0.000456	CcSEcCtD
Topiramate—Flushing—Doxorubicin—sarcoma	0.000313	0.000454	CcSEcCtD
Topiramate—Cardiac disorder—Doxorubicin—sarcoma	0.000313	0.000454	CcSEcCtD
Topiramate—Flatulence—Epirubicin—sarcoma	0.000313	0.000454	CcSEcCtD
Topiramate—Tension—Epirubicin—sarcoma	0.000312	0.000452	CcSEcCtD
Topiramate—Dysgeusia—Epirubicin—sarcoma	0.000311	0.000451	CcSEcCtD
Topiramate—Nervousness—Epirubicin—sarcoma	0.000309	0.000447	CcSEcCtD
Topiramate—Back pain—Epirubicin—sarcoma	0.000307	0.000445	CcSEcCtD
Topiramate—GRIA2—BDNF signaling pathway—JUN—sarcoma	0.000307	0.0015	CbGpPWpGaD
Topiramate—Angiopathy—Doxorubicin—sarcoma	0.000306	0.000444	CcSEcCtD
Topiramate—Dizziness—Etoposide—sarcoma	0.000306	0.000443	CcSEcCtD
Topiramate—Muscle spasms—Epirubicin—sarcoma	0.000306	0.000443	CcSEcCtD
Topiramate—Immune system disorder—Doxorubicin—sarcoma	0.000305	0.000442	CcSEcCtD
Topiramate—GRIA2—BDNF signaling pathway—CTNNB1—sarcoma	0.000305	0.00149	CbGpPWpGaD
Topiramate—SCN5A—L1CAM interactions—EGFR—sarcoma	0.000305	0.00148	CbGpPWpGaD
Topiramate—Mediastinal disorder—Doxorubicin—sarcoma	0.000304	0.000441	CcSEcCtD
Topiramate—Chills—Doxorubicin—sarcoma	0.000303	0.000439	CcSEcCtD
Topiramate—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CREB1—sarcoma	0.0003	0.00146	CbGpPWpGaD
Topiramate—Vision blurred—Epirubicin—sarcoma	0.000299	0.000434	CcSEcCtD
Topiramate—Alopecia—Doxorubicin—sarcoma	0.000298	0.000432	CcSEcCtD
Topiramate—GRIA1—Neuronal System—MDM2—sarcoma	0.000298	0.00145	CbGpPWpGaD
Topiramate—Mental disorder—Doxorubicin—sarcoma	0.000296	0.000429	CcSEcCtD
Topiramate—Ill-defined disorder—Epirubicin—sarcoma	0.000295	0.000427	CcSEcCtD
Topiramate—Vomiting—Etoposide—sarcoma	0.000294	0.000426	CcSEcCtD
Topiramate—Erythema—Doxorubicin—sarcoma	0.000294	0.000426	CcSEcCtD
Topiramate—Malnutrition—Doxorubicin—sarcoma	0.000294	0.000426	CcSEcCtD
Topiramate—Anaemia—Epirubicin—sarcoma	0.000294	0.000425	CcSEcCtD
Topiramate—Agitation—Epirubicin—sarcoma	0.000292	0.000423	CcSEcCtD
Topiramate—Rash—Etoposide—sarcoma	0.000292	0.000423	CcSEcCtD
Topiramate—Dermatitis—Etoposide—sarcoma	0.000291	0.000422	CcSEcCtD
Topiramate—Headache—Etoposide—sarcoma	0.00029	0.00042	CcSEcCtD
Topiramate—Flatulence—Doxorubicin—sarcoma	0.00029	0.00042	CcSEcCtD
Topiramate—SCN1A—Axon guidance—CREB1—sarcoma	0.00029	0.00141	CbGpPWpGaD
Topiramate—Tension—Doxorubicin—sarcoma	0.000289	0.000418	CcSEcCtD
Topiramate—SCN5A—Developmental Biology—PTPRC—sarcoma	0.000288	0.00141	CbGpPWpGaD
Topiramate—Dysgeusia—Doxorubicin—sarcoma	0.000288	0.000417	CcSEcCtD
Topiramate—CA6—Metabolism—ENO2—sarcoma	0.000287	0.0014	CbGpPWpGaD
Topiramate—CA5A—Metabolism—ENO2—sarcoma	0.000287	0.0014	CbGpPWpGaD
Topiramate—Malaise—Epirubicin—sarcoma	0.000287	0.000415	CcSEcCtD
Topiramate—Nervousness—Doxorubicin—sarcoma	0.000286	0.000414	CcSEcCtD
Topiramate—Vertigo—Epirubicin—sarcoma	0.000286	0.000414	CcSEcCtD
Topiramate—CA5A—Metabolism—HBA1—sarcoma	0.000285	0.00139	CbGpPWpGaD
Topiramate—CA6—Metabolism—HBA1—sarcoma	0.000285	0.00139	CbGpPWpGaD
Topiramate—Syncope—Epirubicin—sarcoma	0.000285	0.000413	CcSEcCtD
Topiramate—SCN1A—Developmental Biology—FOXO1—sarcoma	0.000285	0.00139	CbGpPWpGaD
Topiramate—Leukopenia—Epirubicin—sarcoma	0.000284	0.000412	CcSEcCtD
Topiramate—Back pain—Doxorubicin—sarcoma	0.000284	0.000412	CcSEcCtD
Topiramate—GRIA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—sarcoma	0.000284	0.00138	CbGpPWpGaD
Topiramate—Muscle spasms—Doxorubicin—sarcoma	0.000283	0.000409	CcSEcCtD
Topiramate—SCN5A—Developmental Biology—PLCG1—sarcoma	0.000282	0.00138	CbGpPWpGaD
Topiramate—Palpitations—Epirubicin—sarcoma	0.000281	0.000407	CcSEcCtD
Topiramate—Loss of consciousness—Epirubicin—sarcoma	0.000279	0.000405	CcSEcCtD
Topiramate—GRIA1—BDNF signaling pathway—HRAS—sarcoma	0.000277	0.00135	CbGpPWpGaD
Topiramate—Cough—Epirubicin—sarcoma	0.000277	0.000402	CcSEcCtD
Topiramate—Vision blurred—Doxorubicin—sarcoma	0.000277	0.000401	CcSEcCtD
Topiramate—GRIA2—BDNF signaling pathway—SRC—sarcoma	0.000276	0.00134	CbGpPWpGaD
Topiramate—Convulsion—Epirubicin—sarcoma	0.000275	0.000399	CcSEcCtD
Topiramate—Nausea—Etoposide—sarcoma	0.000275	0.000398	CcSEcCtD
Topiramate—Hypertension—Epirubicin—sarcoma	0.000274	0.000397	CcSEcCtD
Topiramate—Ill-defined disorder—Doxorubicin—sarcoma	0.000273	0.000395	CcSEcCtD
Topiramate—GRIA3—Neuronal System—HRAS—sarcoma	0.000273	0.00133	CbGpPWpGaD
Topiramate—GRIK2—Neuronal System—MDM2—sarcoma	0.000272	0.00133	CbGpPWpGaD
Topiramate—GRIA2—Transmission across Chemical Synapses—MDM2—sarcoma	0.000272	0.00133	CbGpPWpGaD
Topiramate—Anaemia—Doxorubicin—sarcoma	0.000272	0.000394	CcSEcCtD
Topiramate—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—sarcoma	0.000272	0.00132	CbGpPWpGaD
Topiramate—Chest pain—Epirubicin—sarcoma	0.000271	0.000392	CcSEcCtD
Topiramate—Arthralgia—Epirubicin—sarcoma	0.000271	0.000392	CcSEcCtD
Topiramate—Myalgia—Epirubicin—sarcoma	0.000271	0.000392	CcSEcCtD
Topiramate—Agitation—Doxorubicin—sarcoma	0.00027	0.000391	CcSEcCtD
Topiramate—Anxiety—Epirubicin—sarcoma	0.00027	0.000391	CcSEcCtD
Topiramate—SCN1A—Axon guidance—MMP2—sarcoma	0.000269	0.00131	CbGpPWpGaD
Topiramate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000269	0.000389	CcSEcCtD
Topiramate—CA5B—Metabolism—ENO2—sarcoma	0.000268	0.00131	CbGpPWpGaD
Topiramate—CA7—Metabolism—ENO2—sarcoma	0.000268	0.00131	CbGpPWpGaD
Topiramate—Discomfort—Epirubicin—sarcoma	0.000267	0.000387	CcSEcCtD
Topiramate—CA5B—Metabolism—HBA1—sarcoma	0.000266	0.0013	CbGpPWpGaD
Topiramate—CA7—Metabolism—HBA1—sarcoma	0.000266	0.0013	CbGpPWpGaD
Topiramate—Malaise—Doxorubicin—sarcoma	0.000265	0.000384	CcSEcCtD
Topiramate—Dry mouth—Epirubicin—sarcoma	0.000265	0.000383	CcSEcCtD
Topiramate—Vertigo—Doxorubicin—sarcoma	0.000264	0.000383	CcSEcCtD
Topiramate—Syncope—Doxorubicin—sarcoma	0.000264	0.000382	CcSEcCtD
Topiramate—Leukopenia—Doxorubicin—sarcoma	0.000263	0.000381	CcSEcCtD
Topiramate—SCN5A—SIDS Susceptibility Pathways—JUN—sarcoma	0.000263	0.00128	CbGpPWpGaD
Topiramate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CREB1—sarcoma	0.000262	0.00128	CbGpPWpGaD
Topiramate—Confusional state—Epirubicin—sarcoma	0.000262	0.000379	CcSEcCtD
Topiramate—SCN5A—SIDS Susceptibility Pathways—CTNNB1—sarcoma	0.000261	0.00127	CbGpPWpGaD
Topiramate—Palpitations—Doxorubicin—sarcoma	0.00026	0.000376	CcSEcCtD
Topiramate—GRIK2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—sarcoma	0.000259	0.00127	CbGpPWpGaD
Topiramate—Oedema—Epirubicin—sarcoma	0.000259	0.000376	CcSEcCtD
Topiramate—Loss of consciousness—Doxorubicin—sarcoma	0.000258	0.000374	CcSEcCtD
Topiramate—Infection—Epirubicin—sarcoma	0.000258	0.000373	CcSEcCtD
Topiramate—Cough—Doxorubicin—sarcoma	0.000257	0.000372	CcSEcCtD
Topiramate—Shock—Epirubicin—sarcoma	0.000255	0.00037	CcSEcCtD
Topiramate—Convulsion—Doxorubicin—sarcoma	0.000255	0.000369	CcSEcCtD
Topiramate—Nervous system disorder—Epirubicin—sarcoma	0.000254	0.000368	CcSEcCtD
Topiramate—Thrombocytopenia—Epirubicin—sarcoma	0.000254	0.000368	CcSEcCtD
Topiramate—Hypertension—Doxorubicin—sarcoma	0.000254	0.000368	CcSEcCtD
Topiramate—Tachycardia—Epirubicin—sarcoma	0.000253	0.000367	CcSEcCtD
Topiramate—Skin disorder—Epirubicin—sarcoma	0.000252	0.000365	CcSEcCtD
Topiramate—GRIA2—Neuronal System—CREB1—sarcoma	0.000252	0.00123	CbGpPWpGaD
Topiramate—Hyperhidrosis—Epirubicin—sarcoma	0.000251	0.000363	CcSEcCtD
Topiramate—Arthralgia—Doxorubicin—sarcoma	0.00025	0.000363	CcSEcCtD
Topiramate—Chest pain—Doxorubicin—sarcoma	0.00025	0.000363	CcSEcCtD
Topiramate—Myalgia—Doxorubicin—sarcoma	0.00025	0.000363	CcSEcCtD
Topiramate—Anxiety—Doxorubicin—sarcoma	0.000249	0.000361	CcSEcCtD
Topiramate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000249	0.00036	CcSEcCtD
Topiramate—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—sarcoma	0.000248	0.00121	CbGpPWpGaD
Topiramate—CA12—Metabolism—ENO2—sarcoma	0.000248	0.00121	CbGpPWpGaD
Topiramate—Discomfort—Doxorubicin—sarcoma	0.000247	0.000358	CcSEcCtD
Topiramate—Anorexia—Epirubicin—sarcoma	0.000247	0.000358	CcSEcCtD
Topiramate—GABRB2—Transmission across Chemical Synapses—CREB1—sarcoma	0.000247	0.0012	CbGpPWpGaD
Topiramate—CA12—Metabolism—HBA1—sarcoma	0.000247	0.0012	CbGpPWpGaD
Topiramate—Dry mouth—Doxorubicin—sarcoma	0.000245	0.000355	CcSEcCtD
Topiramate—CA6—Metabolism—PLCG1—sarcoma	0.000244	0.00119	CbGpPWpGaD
Topiramate—CA5A—Metabolism—PLCG1—sarcoma	0.000244	0.00119	CbGpPWpGaD
Topiramate—Hypotension—Epirubicin—sarcoma	0.000242	0.000351	CcSEcCtD
Topiramate—Confusional state—Doxorubicin—sarcoma	0.000242	0.00035	CcSEcCtD
Topiramate—GABRA1—SIDS Susceptibility Pathways—CREB1—sarcoma	0.000241	0.00117	CbGpPWpGaD
Topiramate—Oedema—Doxorubicin—sarcoma	0.00024	0.000348	CcSEcCtD
Topiramate—CA9—Cellular responses to stress—MDM2—sarcoma	0.00024	0.00117	CbGpPWpGaD
Topiramate—Infection—Doxorubicin—sarcoma	0.000238	0.000345	CcSEcCtD
Topiramate—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000236	0.000342	CcSEcCtD
Topiramate—Shock—Doxorubicin—sarcoma	0.000236	0.000342	CcSEcCtD
Topiramate—SCN1A—Developmental Biology—KDR—sarcoma	0.000236	0.00115	CbGpPWpGaD
Topiramate—Nervous system disorder—Doxorubicin—sarcoma	0.000235	0.000341	CcSEcCtD
Topiramate—Thrombocytopenia—Doxorubicin—sarcoma	0.000235	0.00034	CcSEcCtD
Topiramate—Insomnia—Epirubicin—sarcoma	0.000235	0.00034	CcSEcCtD
Topiramate—Tachycardia—Doxorubicin—sarcoma	0.000234	0.000339	CcSEcCtD
Topiramate—Skin disorder—Doxorubicin—sarcoma	0.000233	0.000338	CcSEcCtD
Topiramate—Paraesthesia—Epirubicin—sarcoma	0.000233	0.000337	CcSEcCtD
Topiramate—SCN5A—Axon guidance—KDR—sarcoma	0.000232	0.00113	CbGpPWpGaD
Topiramate—Hyperhidrosis—Doxorubicin—sarcoma	0.000232	0.000336	CcSEcCtD
Topiramate—Dyspnoea—Epirubicin—sarcoma	0.000231	0.000335	CcSEcCtD
Topiramate—Somnolence—Epirubicin—sarcoma	0.000231	0.000334	CcSEcCtD
Topiramate—SCN5A—SIDS Susceptibility Pathways—VEGFA—sarcoma	0.000229	0.00112	CbGpPWpGaD
Topiramate—Anorexia—Doxorubicin—sarcoma	0.000229	0.000331	CcSEcCtD
Topiramate—Dyspepsia—Epirubicin—sarcoma	0.000228	0.000331	CcSEcCtD
Topiramate—CA5B—Metabolism—PLCG1—sarcoma	0.000227	0.00111	CbGpPWpGaD
Topiramate—CA7—Metabolism—PLCG1—sarcoma	0.000227	0.00111	CbGpPWpGaD
Topiramate—GABRG2—Transmission across Chemical Synapses—CREB1—sarcoma	0.000226	0.0011	CbGpPWpGaD
Topiramate—Decreased appetite—Epirubicin—sarcoma	0.000225	0.000327	CcSEcCtD
Topiramate—Hypotension—Doxorubicin—sarcoma	0.000224	0.000325	CcSEcCtD
Topiramate—Gastrointestinal disorder—Epirubicin—sarcoma	0.000224	0.000324	CcSEcCtD
Topiramate—Fatigue—Epirubicin—sarcoma	0.000224	0.000324	CcSEcCtD
Topiramate—Constipation—Epirubicin—sarcoma	0.000222	0.000321	CcSEcCtD
Topiramate—Pain—Epirubicin—sarcoma	0.000222	0.000321	CcSEcCtD
Topiramate—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000219	0.000317	CcSEcCtD
Topiramate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—sarcoma	0.000217	0.00106	CbGpPWpGaD
Topiramate—Insomnia—Doxorubicin—sarcoma	0.000217	0.000314	CcSEcCtD
Topiramate—Paraesthesia—Doxorubicin—sarcoma	0.000215	0.000312	CcSEcCtD
Topiramate—Dyspnoea—Doxorubicin—sarcoma	0.000214	0.00031	CcSEcCtD
Topiramate—Feeling abnormal—Epirubicin—sarcoma	0.000214	0.00031	CcSEcCtD
Topiramate—Somnolence—Doxorubicin—sarcoma	0.000213	0.000309	CcSEcCtD
Topiramate—GRIA1—Transmission across Chemical Synapses—HRAS—sarcoma	0.000213	0.00104	CbGpPWpGaD
Topiramate—Gastrointestinal pain—Epirubicin—sarcoma	0.000212	0.000307	CcSEcCtD
Topiramate—Dyspepsia—Doxorubicin—sarcoma	0.000211	0.000306	CcSEcCtD
Topiramate—CA12—Metabolism—PLCG1—sarcoma	0.000211	0.00103	CbGpPWpGaD
Topiramate—Decreased appetite—Doxorubicin—sarcoma	0.000209	0.000302	CcSEcCtD
Topiramate—CA9—Cellular responses to stress—JUN—sarcoma	0.000209	0.00102	CbGpPWpGaD
Topiramate—GRIA2—Neuronal System—MDM2—sarcoma	0.000208	0.00102	CbGpPWpGaD
Topiramate—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000207	0.0003	CcSEcCtD
Topiramate—Fatigue—Doxorubicin—sarcoma	0.000207	0.0003	CcSEcCtD
Topiramate—SCN1A—Developmental Biology—CREB1—sarcoma	0.000207	0.00101	CbGpPWpGaD
Topiramate—Urticaria—Epirubicin—sarcoma	0.000206	0.000298	CcSEcCtD
Topiramate—Constipation—Doxorubicin—sarcoma	0.000205	0.000297	CcSEcCtD
Topiramate—Pain—Doxorubicin—sarcoma	0.000205	0.000297	CcSEcCtD
Topiramate—Abdominal pain—Epirubicin—sarcoma	0.000205	0.000297	CcSEcCtD
Topiramate—Body temperature increased—Epirubicin—sarcoma	0.000205	0.000297	CcSEcCtD
Topiramate—GABRB2—Transmission across Chemical Synapses—MDM2—sarcoma	0.000204	0.000995	CbGpPWpGaD
Topiramate—SCN5A—Axon guidance—CREB1—sarcoma	0.000204	0.000992	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—FOXO1—sarcoma	0.0002	0.000976	CbGpPWpGaD
Topiramate—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—sarcoma	0.000198	0.000967	CbGpPWpGaD
Topiramate—CA4—Metabolism—ENO2—sarcoma	0.000198	0.000965	CbGpPWpGaD
Topiramate—Feeling abnormal—Doxorubicin—sarcoma	0.000198	0.000286	CcSEcCtD
Topiramate—GABRA1—Transmission across Chemical Synapses—CREB1—sarcoma	0.000197	0.000962	CbGpPWpGaD
Topiramate—CA4—Metabolism—HBA1—sarcoma	0.000197	0.000959	CbGpPWpGaD
Topiramate—Gastrointestinal pain—Doxorubicin—sarcoma	0.000196	0.000284	CcSEcCtD
Topiramate—GRIK2—Transmission across Chemical Synapses—HRAS—sarcoma	0.000195	0.000951	CbGpPWpGaD
Topiramate—GRIA2—BDNF signaling pathway—HRAS—sarcoma	0.000194	0.000946	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—MMP2—sarcoma	0.000192	0.000938	CbGpPWpGaD
Topiramate—Hypersensitivity—Epirubicin—sarcoma	0.000191	0.000277	CcSEcCtD
Topiramate—Urticaria—Doxorubicin—sarcoma	0.000191	0.000276	CcSEcCtD
Topiramate—CA2—Metabolism—ENO2—sarcoma	0.00019	0.000926	CbGpPWpGaD
Topiramate—Body temperature increased—Doxorubicin—sarcoma	0.00019	0.000275	CcSEcCtD
Topiramate—Abdominal pain—Doxorubicin—sarcoma	0.00019	0.000275	CcSEcCtD
Topiramate—SCN5A—Axon guidance—MMP2—sarcoma	0.000189	0.000924	CbGpPWpGaD
Topiramate—GABRB2—Neuronal System—CREB1—sarcoma	0.000189	0.000922	CbGpPWpGaD
Topiramate—CA2—Metabolism—HBA1—sarcoma	0.000189	0.00092	CbGpPWpGaD
Topiramate—SCN1A—Axon guidance—SRC—sarcoma	0.000187	0.000911	CbGpPWpGaD
Topiramate—GABRG2—Transmission across Chemical Synapses—MDM2—sarcoma	0.000187	0.00091	CbGpPWpGaD
Topiramate—Asthenia—Epirubicin—sarcoma	0.000186	0.00027	CcSEcCtD
Topiramate—Pruritus—Epirubicin—sarcoma	0.000183	0.000266	CcSEcCtD
Topiramate—CA9—Cellular responses to stress—VEGFA—sarcoma	0.000182	0.000888	CbGpPWpGaD
Topiramate—CA1—Metabolism—ENO2—sarcoma	0.000182	0.000887	CbGpPWpGaD
Topiramate—SCN1A—Axon guidance—VEGFA—sarcoma	0.000182	0.000887	CbGpPWpGaD
Topiramate—CA1—Metabolism—HBA1—sarcoma	0.000181	0.000882	CbGpPWpGaD
Topiramate—SCN1A—Axon guidance—NRAS—sarcoma	0.00018	0.000876	CbGpPWpGaD
Topiramate—Diarrhoea—Epirubicin—sarcoma	0.000177	0.000257	CcSEcCtD
Topiramate—Hypersensitivity—Doxorubicin—sarcoma	0.000177	0.000256	CcSEcCtD
Topiramate—GABRA1—SIDS Susceptibility Pathways—JUN—sarcoma	0.000173	0.000844	CbGpPWpGaD
Topiramate—GABRG2—Neuronal System—CREB1—sarcoma	0.000173	0.000843	CbGpPWpGaD
Topiramate—Asthenia—Doxorubicin—sarcoma	0.000172	0.000249	CcSEcCtD
Topiramate—GABRA1—SIDS Susceptibility Pathways—CTNNB1—sarcoma	0.000172	0.000837	CbGpPWpGaD
Topiramate—Dizziness—Epirubicin—sarcoma	0.000172	0.000248	CcSEcCtD
Topiramate—Pruritus—Doxorubicin—sarcoma	0.00017	0.000246	CcSEcCtD
Topiramate—CA4—Metabolism—PLCG1—sarcoma	0.000168	0.000819	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—KDR—sarcoma	0.000166	0.000808	CbGpPWpGaD
Topiramate—Vomiting—Epirubicin—sarcoma	0.000165	0.000239	CcSEcCtD
Topiramate—Diarrhoea—Doxorubicin—sarcoma	0.000164	0.000238	CcSEcCtD
Topiramate—SCN1A—Axon guidance—EGFR—sarcoma	0.000164	0.000798	CbGpPWpGaD
Topiramate—Rash—Epirubicin—sarcoma	0.000164	0.000237	CcSEcCtD
Topiramate—CYP3A4—Tryptophan metabolism—MDM2—sarcoma	0.000163	0.000797	CbGpPWpGaD
Topiramate—GRIA1—Neuronal System—HRAS—sarcoma	0.000163	0.000797	CbGpPWpGaD
Topiramate—Dermatitis—Epirubicin—sarcoma	0.000163	0.000237	CcSEcCtD
Topiramate—GABRA1—Transmission across Chemical Synapses—MDM2—sarcoma	0.000163	0.000796	CbGpPWpGaD
Topiramate—Headache—Epirubicin—sarcoma	0.000162	0.000235	CcSEcCtD
Topiramate—CA2—Metabolism—PLCG1—sarcoma	0.000161	0.000785	CbGpPWpGaD
Topiramate—CA9—Metabolism—ENO2—sarcoma	0.00016	0.00078	CbGpPWpGaD
Topiramate—CA9—Metabolism—HBA1—sarcoma	0.000159	0.000775	CbGpPWpGaD
Topiramate—Dizziness—Doxorubicin—sarcoma	0.000159	0.00023	CcSEcCtD
Topiramate—GABRB2—Neuronal System—MDM2—sarcoma	0.000156	0.000763	CbGpPWpGaD
Topiramate—SCN1A—Axon guidance—KRAS—sarcoma	0.000155	0.000754	CbGpPWpGaD
Topiramate—CA1—Metabolism—PLCG1—sarcoma	0.000154	0.000753	CbGpPWpGaD
Topiramate—Nausea—Epirubicin—sarcoma	0.000154	0.000223	CcSEcCtD
Topiramate—Vomiting—Doxorubicin—sarcoma	0.000153	0.000221	CcSEcCtD
Topiramate—Rash—Doxorubicin—sarcoma	0.000151	0.000219	CcSEcCtD
Topiramate—GABRA1—SIDS Susceptibility Pathways—VEGFA—sarcoma	0.000151	0.000737	CbGpPWpGaD
Topiramate—Dermatitis—Doxorubicin—sarcoma	0.000151	0.000219	CcSEcCtD
Topiramate—GABRA1—Neuronal System—CREB1—sarcoma	0.000151	0.000737	CbGpPWpGaD
Topiramate—Headache—Doxorubicin—sarcoma	0.00015	0.000218	CcSEcCtD
Topiramate—GRIK2—Neuronal System—HRAS—sarcoma	0.000149	0.000729	CbGpPWpGaD
Topiramate—GRIA2—Transmission across Chemical Synapses—HRAS—sarcoma	0.000149	0.000727	CbGpPWpGaD
Topiramate—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—sarcoma	0.000149	0.000727	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—CTNNB1—sarcoma	0.000147	0.000719	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—CREB1—sarcoma	0.000145	0.000708	CbGpPWpGaD
Topiramate—GABRG2—Neuronal System—MDM2—sarcoma	0.000143	0.000698	CbGpPWpGaD
Topiramate—Nausea—Doxorubicin—sarcoma	0.000143	0.000206	CcSEcCtD
Topiramate—CA9—Cellular responses to stress—TP53—sarcoma	0.000138	0.000671	CbGpPWpGaD
Topiramate—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—sarcoma	0.000136	0.000665	CbGpPWpGaD
Topiramate—CA9—Metabolism—PLCG1—sarcoma	0.000136	0.000662	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—MMP2—sarcoma	0.000135	0.000659	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—SRC—sarcoma	0.000133	0.00065	CbGpPWpGaD
Topiramate—SCN1A—Axon guidance—HRAS—sarcoma	0.000131	0.000641	CbGpPWpGaD
Topiramate—SCN5A—Axon guidance—SRC—sarcoma	0.000131	0.00064	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—VEGFA—sarcoma	0.00013	0.000633	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—NRAS—sarcoma	0.000128	0.000625	CbGpPWpGaD
Topiramate—SCN5A—Axon guidance—VEGFA—sarcoma	0.000128	0.000623	CbGpPWpGaD
Topiramate—SCN5A—Axon guidance—NRAS—sarcoma	0.000126	0.000616	CbGpPWpGaD
Topiramate—GABRA1—Neuronal System—MDM2—sarcoma	0.000125	0.00061	CbGpPWpGaD
Topiramate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—sarcoma	0.000119	0.000581	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—EGFR—sarcoma	0.000117	0.00057	CbGpPWpGaD
Topiramate—SCN5A—Axon guidance—EGFR—sarcoma	0.000115	0.000561	CbGpPWpGaD
Topiramate—GRIA2—Neuronal System—HRAS—sarcoma	0.000114	0.000557	CbGpPWpGaD
Topiramate—GABRB2—Transmission across Chemical Synapses—HRAS—sarcoma	0.000112	0.000546	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—KRAS—sarcoma	0.00011	0.000538	CbGpPWpGaD
Topiramate—SCN5A—Axon guidance—KRAS—sarcoma	0.000109	0.00053	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—CTNNB1—sarcoma	0.000104	0.000505	CbGpPWpGaD
Topiramate—GABRG2—Transmission across Chemical Synapses—HRAS—sarcoma	0.000102	0.0005	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—HRAS—sarcoma	9.38e-05	0.000457	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—SRC—sarcoma	9.37e-05	0.000457	CbGpPWpGaD
Topiramate—SCN5A—Axon guidance—HRAS—sarcoma	9.24e-05	0.000451	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—VEGFA—sarcoma	9.13e-05	0.000445	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—NRAS—sarcoma	9.01e-05	0.000439	CbGpPWpGaD
Topiramate—GABRA1—Transmission across Chemical Synapses—HRAS—sarcoma	8.96e-05	0.000437	CbGpPWpGaD
Topiramate—GABRB2—Neuronal System—HRAS—sarcoma	8.58e-05	0.000419	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—EGFR—sarcoma	8.21e-05	0.0004	CbGpPWpGaD
Topiramate—GABRG2—Neuronal System—HRAS—sarcoma	7.85e-05	0.000383	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—KRAS—sarcoma	7.76e-05	0.000378	CbGpPWpGaD
Topiramate—GABRA1—Neuronal System—HRAS—sarcoma	6.86e-05	0.000335	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—HRAS—sarcoma	6.59e-05	0.000322	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—ENO2—sarcoma	4.48e-05	0.000218	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—HBA1—sarcoma	4.45e-05	0.000217	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PLCG1—sarcoma	3.8e-05	0.000185	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—ENO2—sarcoma	2.69e-05	0.000131	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—HBA1—sarcoma	2.68e-05	0.000131	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PLCG1—sarcoma	2.29e-05	0.000111	CbGpPWpGaD
